The US patent system is premised on a fundamental exchange, or as some might say, a grand bargain. In exchange for fully disclosing their invention to the public, the inventor gains the exclusionary right to that invention for a limited period.
The U.S. Supreme Court recently delivered two unanimous decisions, Bowman v. Monsanto (Bowman) and Association for Molecular Pathology v. Myriad Genetics (Myriad). One affirmed industry legal analysis, and the other upended it. In Bowman, the Court held that growing a patented plant and harvesting its seed is equivalent to making the patented seed.